Faculty profile

Brittany Barker

ResearcherCanadian Institute for Substance Use ResearchUniversity of Victoria

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Victoria directory, so their courses may be missing. Find their university profile.

Brittany Barker

Researcher

Canadian Institute for Substance Use Research

Health Sciences

University of Victoria

Victoria, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
10 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Health Policy Mixed Methods Overdose Safer Supply Health Equity Health Service Use Epidemiology Harm Reduction

Latest papers

The characteristics and experiences of parents accessing prescribed safer supply in BC, 2020-2021.
Harm reduction journal · 2026 · senior author
Problem representation of the Risk Mitigation Guidance (RMG) within the context of dual public health emergencies of COVID-19 and toxic drug deaths in British Columbia, Canada.
The International journal on drug policy · 2026
Implementation of risk mitigation prescribing during dual public health emergencies: A qualitative study among Indigenous people who use drugs and health planners in Northern British Columbia, Canada.
The International journal on drug policy · 2025 · first author

All 10 publications

Latest funding

Evolution of prescribed safer supply in Canada: Shifting policy landscapes and implications for population health
CIHR · 2026 · Principal investigator
$1,346,400
A mixed methods evaluation of safer supply initiatives to reduce illicit drug overdose in BC
CIHR · 2021 · Principal investigator
$2,050,200

All 2 grants and awards

10 publications.

The characteristics and experiences of parents accessing prescribed safer supply in BC, 2020-2021.

Hogan K, Macevicius C, McLuckie T, McDougall J, Pauly B, Urbanoski K, Barker B

Harm reduction journal2026Senior author

DOI: 10.1186/s12954-026-01468-0 PMID: 42108468

Problem representation of the Risk Mitigation Guidance (RMG) within the context of dual public health emergencies of COVID-19 and toxic drug deaths in British Columbia, Canada.

Gudiño Pérez D, Macevicius C, Norton A, Beck-McGreevy P, Selfridge M, Kalicum J, Urbanoski K, Barker B, Slaunwhite A, Arredondo J, Wallace B, Pauly B

The International journal on drug policy2026

DOI: 10.1016/j.drugpo.2025.105102 PMID: 41385807

Implementation of risk mitigation prescribing during dual public health emergencies: A qualitative study among Indigenous people who use drugs and health planners in Northern British Columbia, Canada.

Barker B, Norton A, Wood S, Macevicius C, Hogan K, Cadieux K, Meilleur L, Nosyk B, Urbanoski K, Pauly B, Wieman N

The International journal on drug policy2025First author

DOI: 10.1016/j.drugpo.2024.104679 PMID: 39709728

Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.

Pauly BB, Kurz M, Dale LM, Macevicius C, Kalicum J, Pérez DG, McCall J, Urbanoski K, Barker B, Slaunwhite A, Lindsay M, Nosyk B

Journal of substance use and addiction treatment2024

DOI: 10.1016/j.josat.2024.209341 PMID: 38490334

Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt.

Min JE, Guerra-Alejos BC, Yan R, Palis H, Barker B, Urbanoski K, Pauly B, Slaunwhite A, Bach P, Ranger C, Heaslip A, Nosyk B

JAMA network open2024

DOI: 10.1001/jamanetworkopen.2024.11389 PMID: 38748421

COVID-19 vaccination among young people who use drugs in Vancouver, Canada.

McAdam E, Hayashi K, Barker B, Reddon H, Choi J, Kerr T, DeBeck K

Vaccine2024

DOI: 10.1016/j.vaccine.2024.01.003 PMID: 38225183

Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.

Slaunwhite A, Min JE, Palis H, Urbanoski K, Pauly B, Barker B, Crabtree A, Bach P, Krebs E, Dale L, Meilleur L, Nosyk B

BMJ (Clinical research ed.)2024

DOI: 10.1136/bmj-2023-076336 PMID: 38199614

Influence of physician networks on the implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia.

Kurz M, Guerra-Alejos BC, Min JE, Barker B, Pauly B, Urbanoski K, Nosyk B

Implementation science : IS2024

DOI: 10.1186/s13012-023-01331-x PMID: 38184548

Doing community-based research during dual public health emergencies (COVID and overdose).

Beck McGreevy P, Wood S, Thomson E, Burmeister C, Spence H, Pelletier J, Giesinger W, McDougall J, McLeod R, Hutchison A, Lock K, Norton A, Barker B, Urbanoski K, Slaunwhite A, Nosyk B, Pauly B

Harm reduction journal2023

DOI: 10.1186/s12954-023-00852-4 PMID: 37715202

Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.

Giang K, Charlesworth R, Thulien M, Mulholland A, Barker B, Brar R, Pauly B, Fast D

The International journal on drug policy2023

DOI: 10.1016/j.drugpo.2023.104023 PMID: 37059025

Something wrong or missing on this profile? Suggest a correction

Brittany Barker

Research

Latest papers

Latest funding

The characteristics and experiences of parents accessing prescribed safer supply in BC, 2020-2021.

Problem representation of the Risk Mitigation Guidance (RMG) within the context of dual public health emergencies of COVID-19 and toxic drug deaths in British Columbia, Canada.

Implementation of risk mitigation prescribing during dual public health emergencies: A qualitative study among Indigenous people who use drugs and health planners in Northern British Columbia, Canada.

Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.

Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt.

COVID-19 vaccination among young people who use drugs in Vancouver, Canada.

Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.

Influence of physician networks on the implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia.

Doing community-based research during dual public health emergencies (COVID and overdose).

Risk mitigation guidance and safer supply prescribing among young people who use drugs in the context of COVID-19 and overdose emergencies.

Evolution of prescribed safer supply in Canada: Shifting policy landscapes and implications for population health

A mixed methods evaluation of safer supply initiatives to reduce illicit drug overdose in BC

Frequent collaborators

Brittany Barker

Karen Urbanoski

Bohdan Nosyk

Amanda Slaunwhite

Bohdan Nosyk

Heather Palis

Paxton Bach

Karen Urbanoski

Hudson Reddon

Bruce Wallace

Thomas Kerr

Kurt Lock

Kora DeBeck

Bernadette Pauly

Kanna Hayashi

Danya Fast

Kanna Hayashi